BioPharm International
CONTINUE TO SITE

OR WAIT null SECS

Advertisement
BioPharm International
Spotlight
COVID-19 UpdateAnalyticsDevelopmentDownstream ProcessingManufacturingOutsourcingQuality/GMPsUpstream Processing
Topic
View MoreAnalytical MethodsBioBusinessCell Culture/FermentationContinuous ProcessingDrug DeliveryFill/FinishFormulationProcess ChromatographyProcess Control/PATProcess DevelopmentQA/QCSeparation and PurificationSingle-Use SystemsSupply Chain
News
All NewsTop NewsBio/Pharma NewsIndustry NewsSupplier NewsEvents
Publications
All PublicationsBioPharm International
Resources
Podcast SeriesBiopharma InsightsInteractive ToolsSponsored eBooksSponsored PodcastsSponsored VideosWhitepapers
Webcasts
Subscribe
EnewsMagazine

  • About Us
  • Advertise
  • Editorial Information
  • Contact Us
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
  • MJHLS Brand Logo

© 2023 MJH Life Sciences and BioPharm International. All rights reserved.

Spotlight
  • COVID-19 Update
  • Analytics
  • Development
  • Downstream Processing
  • Manufacturing
  • Outsourcing
  • Quality/GMPs
  • Upstream Processing
TopicSee All >
  • Analytical Methods
  • BioBusiness
  • Cell Culture/Fermentation
  • Continuous Processing
  • Drug Delivery
  • Fill/Finish
  • Formulation
  • Process Chromatography
  • Process Control/PAT
  • Process Development
  • QA/QC
  • Separation and Purification
  • Single-Use Systems
  • Supply Chain
  • About Us
  • Advertise
  • Editorial Information
  • Contact Us
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.

Featured Content

Determining and Optimizing Dynamic Binding Capacity

Determining and Optimizing Dynamic Binding Capacity

The breakthrough approach is commonly used, but the devil is in the details.

Purification of Protein by HIC: Mechanistic Modeling for Improved Understanding and Process Optimization

Purification of Protein by HIC: Mechanistic Modeling for Improved Understanding and Optimization

In this article, a simple chromatographic model is proposed that is capable of predicting the impact of pH and ionic strength on HIC chromatograms.

Ramping Up Development of Nucleic Acid Therapies

Ramping Up Development of Nucleic Acid Therapies

The COVID-19 vaccines opened the door to powerful market potential for other nucleic acid-based therapies.

Exploring the Impact of Fixed-Bed Bioreactors in Upstream Processing

Exploring the Impact of Fixed-Bed Bioreactors in Upstream Processing

The innovation of going from stainless-steel bioreactors to fixed-bed bioreactors shows an evolution in upstream optimization.

Reducing Vulnerabilities in Upstream and Downstream Supply Chains

Reducing Vulnerabilities in Upstream and Downstream Supply Chains

Makers of specialty biologics, gene therapies, and other personalized medicines are working to identify and reduce potential supply chain risks both upstream and downstream.

Kudos and Hurdles in Tackling Rare Diseases

Kudos and Hurdles in Tackling Rare Diseases

FDA has spurred investment to create and develop 600 therapies.

Zauberkugel: Pfizer’s Seagen Acquisition

Zauberkugel: Pfizer’s Seagen Acquisition

What can we take away from Pfizer's acquisition of Seagen?